Responses
ABSTRACT: Poster Session 3: Endometrium/Ovarian/Breast/GTD - Tuesday, October 17, 2006
0646: Analysis of Her-2/Neu in Recurrent Endometrial Cancer: Limited Clinical Benefit From Trastuzu-Mab (Herceptin°)
Compose a Response to This Article
Other responses
No responses have been published for this article.